Citation Impact
Citing Papers
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq
2015 StandoutScience
Exercise training increases size of hippocampus and improves memory
2011 Standout
Structural Neuroimaging Studies in Major Depressive Disorder
2011
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
Depression
2018 Standout
Altered gene expression in the superior temporal gyrus in schizophrenia
2008
TREM2 in CNS homeostasis and neurodegenerative disease
2015
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Understanding Synapses: Past, Present, and Future
2008 StandoutNobel
Role of glutamate in schizophrenia: integrating excitatory avenues of research
2008
Development of a minimum data set-based depression rating scale for use in nursing homes
2000
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
Untangling Genetic Risk for Alzheimer’s Disease
2017
Alzheimer Mechanisms and Therapeutic Strategies
2012
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies
2013
Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities
2000
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease
2015
Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
2015
Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)
2001 Standout
Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
2010
Advances in the early detection of Alzheimer's disease
2004
Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies
2004
Alzheimer's disease
2011 Standout
Amyloid imaging in mild cognitive impairment subtypes
2009
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Are Depressive Symptoms a Risk Factor for Mortality in Elderly Japanese American Men?: The Honolulu-Asia Aging Study
2002
Mild Cognitive Impairment
2011 Standout
Practice guideline update summary: Mild cognitive impairment [RETIRED]
2017 Standout
Autonomous Neurobiological Pathways to Late-Life Major Depressive Disorder Clinical and Pathophysiological Implications
2002
Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review
2002
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Monetary Costs of Dementia in the United States
2013 Standout
CSF markers for incipient Alzheimer's disease
2003
Depression in Late Life: Review and Commentary
2003 Standout
Familial Dementia With Lewy Bodies
2002
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis
2010
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Metazoan MicroRNAs
2018 Standout
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Marked Differences in Antidepressant Use by Race in an Elderly Community Sample: 1986–1996
2000
Depression and risk of developing dementia
2011
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Behavioral and Psychological Symptoms of Dementia
2012
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Minor and Major Depression and the Risk of Death in Older Persons
1999
Rethinking schizophrenia
2010 StandoutNature
Greater Loss of 5-HT2A Receptors in Midlife Than in Late Life
2002
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
New insights into the role of TREM2 in Alzheimer’s disease
2018
Network biology concepts in complex disease comorbidities
2016
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Long-Term Cognitive Impairment after Critical Illness
2013 Standout
Dendritic spine pathology in schizophrenia
2012
Meta-analyses of genetic studies on major depressive disorder
2007
Animal models of neuropsychiatric disorders
2010
Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram
2002
Genetics of Alzheimer’s Disease
2014
Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease
2011
Alzheimer's Disease
2004 Standout
Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion
2016
Four year follow-up study after unilateral pallidotomy in advanced Parkinson's disease
2002
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>
1999 Standout
Further analyses of the Delirium Rating Scale
1995
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
2009 StandoutNature
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial
2003
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Delirium among patients with and without dementia: does the diagnosis according to the DSM‐IV differ from the previous classifications?
2004
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Depression as a risk factor for non-suicide mortality in the elderly
2002
Delirium in Older Persons
2006 Standout
Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
2008
Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm
2001
Delirium in Mechanically Ventilated Patients
2001 Standout
Management of agitation and aggression associated with Alzheimer disease
2009
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
2006
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples
2006
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease
2003
A catechol- O -methyltransferase that is essential for auditory function in mice and humans
2008 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Age, Alzheimer disease, and brain structure
2009
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
2002
Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
2000
The Computational Anatomy of Psychosis
2013
Escitalopram versus citalopram: the surprising role of the R-enantiomer
2004
Cortical inhibitory neurons and schizophrenia
2005 Standout
Relationship Between Symptoms and Motoric Subtype of Delirium
2000
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
2005
The effectiveness of the treatment of depression in the physically ill elderly
2000
Spermidine in health and disease
2018 StandoutScience
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Pavlovian conditioning–induced hallucinations result from overweighting of perceptual priors
2017 StandoutScience
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Neuroleptic drugs in dementia: benefits and harm
2006
Delirium in the Hospitalised Elderly
2001
Effect of Citalopram on Agitation in Alzheimer Disease
2014
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Mild cognitive impairment, amnestic type
2004
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve
2009
Emerging Targets in Photopharmacology
2016 StandoutNobel
Psychiatric Diagnosis and Intervention in Older and Younger Patients in a Primary Care Clinic: Effect of a Screening and Diagnostic Instrument
1998
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
2008 StandoutScience
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
2020 Standout
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Characteristics and Course of Major Depression in Older Primary Care Patients
1998
Works of Robert A. Sweet being referenced
A Few Corrections to Our Article
2002
Effect of Nortriptyline and Paroxetine on Extrapyramidal Signs and Symptoms: A Prospective Double-Blind Study in Depressed Elderly Patients
2000
Genome-wide copy-number variation study of psychosis in Alzheimer’s disease
2015
A Twelve-Week, Double-Blind, Randomized Comparison of Nortriptyline and Paroxetine in Older Depressed Inpatients and Outpatients
2001
The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis
2008
Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology
2011
Medical comorbidity in elderly psychiatric inpatients
1997
The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease
2001
Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with Schizophrenia
2002
Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain
1998
Auditory dysfunction in schizophrenia: integrating clinical and basic features
2015
Comparison of Citalopram, Perphenazine, and Placebo for the Acute Treatment of Psychosis and Behavioral Disturbances in Hospitalized, Demented Patients
2002
The Effects of Perphenazine on the Concentration of Nortriptyline and its Hydroxymetabolites in Older Patients
1997
APOE is associated with age‐of‐onset, but not cognitive functioning, in late‐life depression
2003
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits
2004
Regional specificity of chandelier neuron axon terminal alterations in schizophrenia
2005
Dopamine Receptor Genetic Variation, Psychosis, and Aggression in Alzheimer Disease
1998
The Use of the Hamilton Rating Scale for Depression in Elderly Patients With Cognitive Impairment and Physical Illness
1994
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
2009
New Atypical Antipsychotics
1998
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
2002
Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology
2002
Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features
2000
Pharmacokinetics of Single‐ and Multiple‐Dose Bupropion in Elderly Patients with Depression
1995
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease
2016
Anatomical Evidence of Impaired Feedforward Auditory Processing in Schizophrenia
2006
Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease
2005
MRI changes in schizophrenia in late life: a preliminary controlled study
1996
Trajectory of Cognitive Decline as a Predictor of Psychosis in Early Alzheimer Disease in the Cardiovascular Health Study
2010
Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE
2011
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
2009
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease
2011
Comorbid anxiety disorders in late-life depression
1996
Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque Monkeys
2007
Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia
2009
Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia
2008
Altered Cortical Glutamate Neurotransmission in Schizophrenia
2003
Incidence of Dementia in Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study
2007
Depressed Mood is Not a Risk Factor for Incident Dementia in a Community-Based Cohort
2009
Neuropathologic Correlates of Late-Onset Major Depression
2004
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk
2015
The Delirium Rating Scale in a psychogeriatric inpatient setting
1994
Mortality of elderly patients with psychiatric disorders
1997
A trial of buspirone for the control of disruptive behaviors in community‐dwelling patients with dementia
1994
Increased familial risk of the psychotic phenotype of Alzheimer disease
2002
Reliability and applicability of movement disorder rating scales in the elderly
1993
Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study–Cognition Study
2012
Is Delirium Different When It Occurs in Dementia?
1998
An Open Pilot Study of Citalopram for Behavioral Disturbances of Dementia Plasma Levels and Real-Time Observations
1997
Test–retest variability of serotonin 5‐HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain
1998
Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I
2000
Effect of Alzheimer’s Disease Risk Genes on Trajectories of Cognitive Function in the Cardiovascular Health Study
2012
Impact of acute psychiatric inpatient treatment on major depression in late life and prediction of response
1994
Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II
2000
Plasma levels of citalopram enantiomers and metabolites in elderly patients.
1997
Determinants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders
1998
Psychiatric Symptoms Vary With the Severity of Dementia in Probable Alzheimer's Disease
2003